Income Statement Numans Health Food Holdings Company Limited
Equities
2530
KYG6781U1085
Food Processing
|
Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
| 0.5300 HKD | 0.00% |
|
+1.92% | -14.52% |
| Fiscal Period: December | 2021 | 2022 | 2023 | 2024 |
|---|---|---|---|---|
Revenues | 338M | 367M | 427M | 277M |
Total Revenues | 338M | 367M | 427M | 277M |
Cost of Goods Sold, Total | 96.92M | 118M | 111M | 65.23M |
Gross Profit | 241M | 250M | 315M | 212M |
Selling General & Admin Expenses, Total | 79.49M | 94.07M | 122M | 112M |
Other Operating Expenses | -3.74M | 52.77M | -10.66M | -9.39M |
Other Operating Expenses, Total | 75.74M | 147M | 111M | 103M |
Operating Income | 165M | 103M | 205M | 110M |
Interest Expense, Total | -117K | -375K | -332K | -259K |
Interest And Investment Income | 477K | 718K | 2.19M | 3.17M |
Net Interest Expenses | 360K | 343K | 1.86M | 2.91M |
Currency Exchange Gains (Loss) | -458K | 50K | 1.16M | -1.24M |
Other Non Operating Income (Expenses) | -10.72M | -5.95M | -12.95M | - |
EBT, Excl. Unusual Items | 154M | 97.2M | 195M | 111M |
Gain (Loss) On Sale Of Assets | - | -90K | -16K | -8K |
Legal Settlements | - | 1.31M | 60K | 183K |
Other Unusual Items | - | - | - | -12.1M |
EBT, Incl. Unusual Items | 154M | 98.41M | 195M | 99.47M |
Income Tax Expense | 34.46M | 10.89M | 35.28M | 24.57M |
Earnings From Continuing Operations | 120M | 87.52M | 159M | 74.9M |
Net Income to Company | 120M | 87.52M | 159M | 74.9M |
Net Income - (IS) | 120M | 87.52M | 159M | 74.9M |
Net Income to Common Incl Extra Items | 120M | 87.52M | 159M | 74.9M |
Net Income to Common Excl. Extra Items | 120M | 87.52M | 159M | 74.9M |
Per Share Items | ||||
Net EPS - Basic | - | - | - | 0.1 |
Basic EPS - Continuing Operations | - | - | - | 0.1 |
Basic Weighted Average Shares Outstanding | - | - | - | 750M |
Net EPS - Diluted | - | - | - | 0.1 |
Diluted EPS - Continuing Operations | - | - | - | 0.1 |
Diluted Weighted Average Shares Outstanding | - | - | - | 750M |
Normalized Basic EPS | - | - | - | 0.09 |
Normalized Diluted EPS | - | - | - | 0.09 |
Dividend Per Share | - | - | - | 0.05 |
Payout Ratio | 22.57 | 5.7 | 50.21 | 146.86 |
Supplemental Items | ||||
EBITDA | 166M | 104M | 206M | 111M |
EBITA | 165M | 103M | 205M | 110M |
EBIT | 165M | 103M | 205M | 110M |
EBITDAR | 166M | 104M | 206M | 111M |
Effective Tax Rate - (Ratio) | 22.36 | 11.07 | 18.13 | 24.7 |
Current Domestic Taxes | 34.29M | 32.05M | 28.95M | 14.67M |
Total Current Taxes | 34.29M | 32.05M | 28.95M | 14.67M |
Total Deferred Taxes | 162K | -21.16M | 6.33M | 9.9M |
Normalized Net Income | 96.33M | 60.75M | 122M | 69.62M |
Interest on Long-Term Debt | 117K | 375K | 332K | 259K |
Supplemental Operating Expense Items | ||||
Advertising Expense | 25.56M | 31.2M | 49.74M | - |
Selling and Marketing Expenses | 63.81M | 79M | 103M | 90.57M |
General and Administrative Expenses | 15.68M | 15.06M | 19M | 21.37M |
Net Rental Expense, Total | 15K | 38K | 74K | 74K |
Imputed Operating Lease Interest Expense | - | 26.29K | 29.61K | 29.89K |
Imputed Operating Lease Depreciation | - | 11.71K | 44.39K | 44.11K |
Select your edition
All financial news and data tailored to specific country editions
















